» Factor VIII Deficient Plasma Native

ROUTINE LYOPHILIZED CONGENITAL DEFICIENT PLASMAS INTRINSIC PATHWAY

Factor VIII Deficient Plasma Native

Lyophilized plasmas

Plasma deficient for the determination of Factor VIII.

Factor VIII Deficient Plasma Native is made from a pool of plasmas from hemophiliac A donors, native (congenital deficiency), lyophilized, having a coagulant activity <1% for FVIII.
All other coagulation factors have normal values. VWF level is normal.

Reference	Presentation	Packaging	Number of assays
4-5154007	Vial	5 x 1.0 mL	100
4-5154016	Vial	50 x 1.0 mL	1 000

Price list, safety data sheets and notices are accessible to our registered customers.

Factor VIII is a glycoprotein mainly synthesized by the liver.
It circulates in the plasma in the form bound to VWF which protects it from rapid proteolytic degradation.
It is activated by FXa or thrombin in FVIIIa which will complex with FIXa in the presence of phospholipids to activate FX in FXa.
A patient who is deficient in FVIII has hemophilia A.

- Deficient human plasma, stabilized and lyophilized with an activity <1% of the corresponding coagulation factor.
- All other coagulation factors have normal values.
- Plasma deficient in native FVIII is used for the determination of FVIII by a one-step method based on Activated Cephalin Time (TCA).
- Does not contain inhibitors.

- 5 or 50 vials x 1 mL lyophilized plasma

Coagulation Control A
Coagulation Control N
Coagulation Reference

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer.
	Distributor.

ROUTINE LYOPHILIZED CONGENITAL DEFICIENT PLASMAS INTRINSIC PATHWAY

Factor VIII Deficient Plasma Native

Lyophilized plasmas

Price list, safety data sheets and notices are accessible to our registered customers.

Cryopep Catalogue
Thrombosis Haemostasis 2023

Cryopep Catalogue
Haemostasis Research 2023

Cryopep LYOPHILIZED CONGENITAL DEFICIENT PLASMAS

Product sheet Factor VIII Deficient Plasma Native

T-TAS® 01 New

You must identify yourself to search for a certificate of analysis

Factor VIII Deficient Plasma Native

Lyophilized plasmas

Product sheet

Price list, safety data sheets and notices are accessible to our registered customers.